2015年8月11日星期二

Statins improve the risk of memory decline

Recently, a study published in JAMA in the United States from the United States, statins and do not take cholesterol lowering drugs directly call or related individuals and statins in memory to loss.When statins and 30 days to lower the cholesterol statins, compared to patients with no medication, medication of patients with memory loss occurred.

But the researchers said the Medical Association, because patients are often associated with medical conditions and drug efficacy, it is convenient for doctors to find their memory loss symptoms, in the use of statins to describe a number of cases and acute memory loss directly related, but the study shows that long-term use of statins to improve individual memory or memory of individuals are not.

The researchers compared the use of statins in two patients and the other 482543 control groups: non lipid lowering drugs (LLDs) 482543 individuals and 26484 non statin drugs, such as the test to the study of the amino acid, chlorine, hydrochloric acid test as the ester, etc.; at the same time, the researchers also conducted a cross study of two cases, the use of diagnostic criteria, personal memory loss related data.

The researchers compared statin users and any personal cholesterol lowering drugs. After 30 days of treatment with statins, the risk of memory decline began, and that any individual cholesterol lowering drugs were not personal, and the researchers found that the drug was associated with an increased risk of memory loss after 30 days.

Finally, the researchers said, the experiment, or all of the drugs will cause acute individual memory loss, which is likely to lead to memory loss, and may be related to the possibility of testing bias, bias and the possibility of testing may be very high, late, of course, the study will be tested in patients with preventive treatment, such as patients taking cholesterol lowering drugs.

Read more:http://about.cusabio.com/m-177.html

没有评论:

发表评论